Coronavirus test maker Novacyt is up 900%. Here’s what I’d do now

Coronavirus is front page news across the globe. AIM-listed UK biotech firm Novacyt has a test for the virus. Is it a storming buy or a stock you’ll regret?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Novacyt (LSE:NCYT) is on a rocket ride as the biotech minnow announced the first European-approved coronavirus testing kits.

The largely-unknown AIM-listed firm has shot to the top of Hargreaves Lansdown’s most-traded shares list.

But investors should be wary of such a huge and rapid boom in retail interest.

Should you invest £1,000 in 3i Group Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if 3i Group Plc made the list?

See the 6 stocks

Up 900% – FOMO?

The NCYT share price has increased by 887% in the last month alone. Zoom out to six months and the share price is nearly 2,000% higher than it was.

It’s natural to want to get a piece of the action when you see such a massive spike, even if you have no other AIM-listed shares in your Stocks and Shares ISA or SIPP.

However, in an ideal world, investors would not be swayed by FOMO, or ‘fear of missing out’, when it comes to choosing what to do with their hard-earned capital.

Early investors in NCYT are now taking their profits. As of noon on 19 February the shares have sunk 27% from their 166p high. £10m has been wiped off the company’s market cap in the last 24 hours alone.

Momentum

With momentum trades — where investors jump on board based not on fundamentals, or profits, but on price action alone — the fall on the other side of the hill is usually just as hard as the rise is impressive.

History tells us that flash-in-the-pan contenders don’t tend to last. No matter how staggering a share price rise seems, massive new interest in a previously unheard-of stock will deflate eventually.

And then selling out at a reasonable price is a lot harder than buying in.

While I do own a few AIM-listed stocks and shares, like video game developer Frontier Developments and multinational marketing firm The Mission Group, these are highly profitable enterprises with solid, long-term track records and high-margin sales growth. The same can’t be said for Novacyt.

Volatile

Coronavirus has been front page news around the world since the outbreak in the Chinese city of Wuhan in late 2019. Biotech firms have been racing to develop tests and potential vaccines for the virus.

Primerdesign, Novacyt’s molecular diagnostics division, launched a new laboratory-based test to detect the virus coronavirus on 31 January 2020.

While saying his company had received 288,000 preorders for tests from countries including the US, UK, and China, chief executive Graham Mullis admitted it was difficult to predict long-term demand for the molecular tests.

Day traders and swing traders who sit in front of screens all day every day may be able to get in and out rapidly, but the same can’t be said for the likes of you and me.

My play here would be to ignore the short-term rockets and focus on longer-term growth. While you might feel out of the loop while FOMO-chasers crow about getting rich, when the hype fades you’ll likely be in a much better position than they are.

I think the Novacyt share price has only one way to go, and I wouldn’t want to be on the wrong side of it.

But this isn’t the only opportunity that’s caught my attention this week. Here are:

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tom Rodgers has no long or short position in Novacyt. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Here’s how a 40-year-old could start investing £100 per week to retire early

If a 40-year-old decides to start investing today, here's how they could potentially turn £100 a week into over £500k…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

The FTSE 100 is up 60% in 5 years. Here’s why — and a big lesson!

The flagship FTSE 100 index has put in a very strong performance over five years. There's a specific reason for…

Read more »

Investing Articles

How much do investors need in an ISA to earn a £2,500 monthly passive income?

Charlie Carman explores how investors could strive for £30k in tax-free passive income each year from a dividend stock portfolio.

Read more »

Investing Articles

How much would a 45-year-old need to invest in an ISA to earn a £1k monthly passive income at 65?

Harvey Jones looks at how much an investor would need to put away every month to build a steady passive…

Read more »

Investing Articles

3 things to do ahead of the new 2025-26 ISA year

It's time for us all to put on our investing boots and get to work on developing our plans for…

Read more »

Older couple walking in park
Investing Articles

Is £150,000 enough to generate £1,000 a month in passive income?

Stephen Wright takes a look at three UK stocks with dividend yields above 8% that passive income investors might be…

Read more »

Investing Articles

Aim to earn a £50k second income in retirement by investing just this much each month

Even with a small monthly investment, it’s possible to earn a £50k second income with a successful investment strategy and…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Down 22% in a month! Is this my chance to buy shares in this FTSE 100 outperformer?

Shares in InterContinental Hotels Group have outperformed the FTSE 100 over the long term. So is a chance to buy…

Read more »